Clinical trial of atezolizumab plus chemotherapy compared with chemotherapy alone for patients with recurrent triple-negative breast cancer (IMpassion132)
A Study of the Efficacy and Safety of Atezolizumab Plus Chemotherapy for Patients With Early Relapsing Recurrent Triple-Negative Breast Cancer (IMpassion132)
Cancer Breast Cancer Triple Negative Breast Neoplasms Triple Negative Breast Cancer
For the latest version of this information please go to www.forpatients.roche.com